DEF 14A

Company

ENDRA Life Sciences Inc.

Filed

October 28, 2025

Period of Report

December 31, 2024

Accession Number

0001654954-25-012254

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →